Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02525094 · ClinicalTrials.gov registry record · Phase 2
Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
A Phase 2 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 2
- Development phase
- 113
- Enrollment target
NCT02525094 is a Phase 2 study that has completed, run by MedImmune. The registered enrollment target is 113 participants.
The verdict
NCT02525094, a Phase 2 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 113 participants
- Enrollment target
Study Summary
To assess the efficacy and safety of MEDI9929 in adult subjects with Atopic Dermatitis
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL MEDI9929
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2015-08-15 |
| Est. Completion | 2016-07-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02525094
The ClinicalTrials.gov registry entry for NCT02525094 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02525094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02525094 about?
NCT02525094 is a clinical study titled "Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis". To assess the efficacy and safety of MEDI9929 in adult subjects with Atopic Dermatitis
What is the current status of trial NCT02525094?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 113 participants. The study started on 2015-08-15. Estimated completion is 2016-07-15.
What interventions are being tested in trial NCT02525094?
The interventions under investigation include: Placebo (BIOLOGICAL), MEDI9929 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02525094?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.